Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morie Gertz

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
European Heart Journal|April 14, 2007
Vascular abnormalities in primary amyloidosisKaren M Modesto, Angela Dispenzieri, Morie Gertz, et al.
American Journal of Hematology|February 13, 2021
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapyKitsada Wudhikarn, Leslie Padrnos, Terra Lasho, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2026
Diagnostic Journeys and Delays in AL Amyloidosis: Insights From a Cross-Sectional Patient SurveyNadine H Abdallah, Jay R Hydren, Mason S Barnes, et al.
American Journal of Clinical Pathology|August 29, 2025
Gallbladder amyloidosis is often unexpected and may have systemic implicationsCatherine E Hagen, Surendra Dasari, Jason D Theis, et al.
American Journal of Hematology|March 20, 2013
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphomaTaxiarchis V Kourelis, Morie Gertz, Clive Zent, et al.
Blood Cancer Journal|September 23, 2021
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)Matthew Ho, Saurabh Zanwar, Prashant Kapoor, et al.
Blood Advances|December 5, 2024
Prognostic impact of patient-reported symptoms in multiple myelomaNadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, et al.
Blood|July 15, 2006
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implicationsNatalia Gonzalez-Paz, Wee J Chng, Rebecca F McClure, et al.
Haematologica|April 21, 2018
Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Bone Marrow Transplantation|June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosisNadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
European Heart Journal|April 14, 2007
Vascular abnormalities in primary amyloidosisKaren M Modesto, Angela Dispenzieri, Morie Gertz, et al.
American Journal of Hematology|February 13, 2021
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapyKitsada Wudhikarn, Leslie Padrnos, Terra Lasho, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2026
Diagnostic Journeys and Delays in AL Amyloidosis: Insights From a Cross-Sectional Patient SurveyNadine H Abdallah, Jay R Hydren, Mason S Barnes, et al.
American Journal of Clinical Pathology|August 29, 2025
Gallbladder amyloidosis is often unexpected and may have systemic implicationsCatherine E Hagen, Surendra Dasari, Jason D Theis, et al.
American Journal of Hematology|March 20, 2013
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphomaTaxiarchis V Kourelis, Morie Gertz, Clive Zent, et al.
Blood Cancer Journal|September 23, 2021
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)Matthew Ho, Saurabh Zanwar, Prashant Kapoor, et al.
Blood Advances|December 5, 2024
Prognostic impact of patient-reported symptoms in multiple myelomaNadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, et al.
Blood|July 15, 2006
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implicationsNatalia Gonzalez-Paz, Wee J Chng, Rebecca F McClure, et al.
Haematologica|April 21, 2018
Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Bone Marrow Transplantation|June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosisNadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
Pageof 12